CE Mark for ProFound AI for 2D mammography software system to analyze 2D mammography scans . ICAD

ICAD, has secured European CE Mark approval for its ProFound AI for 2D Mammography software system. The product relies on a �high-functioning, deep learning� artificial intelligence algorithm to analyze 2D mammography scans and point out potential areas of concern.

The software package provides �Certainty of Finding� and �Case Scores� for each instance of a suspect lesion that it identifies, helping radiologists better focus on what�s important while quickening and improving the quality of diagnosis.The system works by noticing slight changes in soft tissue densities and spotting calcifications, and because the company is working on improving the quality of its algorithm, future updates are expected to further benefit physicians and patients.

ProFound AI is a high-performance, deep-learning, cancer detection and workflow solution for DBT delivering critical benefits to radiologists, their facilities, and their patients through improvement of cancer detection rates by an average of 8 percent and decreasing unnecessary patient recall rates by an average of 7 percent. The new technology is trained to detect malignant soft-tissue densities and calcifications. It also provides radiologists with scoring information representing the likelihood that a detection or case is malignant based on the large dataset of clinical images used to train the algorithm. In addition to improving clinical performance related to breast cancer detection and false positive rates, study results showed that ProFound AI can reduce radiologists� reading time by more than 50 percent on average. An increase in reading time has been a significant challenge for radiologists when moving from 2D to 3D mammography.The solution is currently available for use with leading DBT systems in the U.S., Canada and Europe.